Claritas Pharmaceuticals Inc CLAZF

RE:Kaltf. Usd

[Red~One]

When the Junior Pharma sector crashed a year ago many folks sold and moved on. Others trimmed their portfolios and held on to their favourites. The odds of a junior pharma stock making it all the way to a successful Phase 3 are staggeringly low. Everyone at some time feels that their choice of miracle product are going to be life changing for the industry and for themselves. It takes about $35 million U$ to take a therapy thru Phase 1 to 3, and that's not counting normal Company operating costs and other day to day admin. The daily volume will show you how much interest is there for your favourite stock. Hopefully things change for you before May.

[SeeDonRun]

Hi Red, the health benefits of NO are very well documented and, as seen by the recent news of certain companies with different ways of delivering it, they are doing very well, Clas with their unique liquid NO formula may provide some pretty good financial benefits for shareholders as well so I wouldn't discount them. My understanding (of course I could be wrong) is that Clas is a research and